- Home
- FFBC vs DNLI Comparison
FFBC vs DNLI Comparison
Compare FFBC & DNLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FFBC
- DNLI
- Stock Information
- Founded
- FFBC 1863
- DNLI 2013
- Country
- FFBC United States
- DNLI United States
- Employees
- FFBC N/A
- DNLI N/A
- Industry
- FFBC Major Banks
- DNLI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FFBC Finance
- DNLI Health Care
- Exchange
- FFBC Nasdaq
- DNLI Nasdaq
- Market Cap
- FFBC 2.3B
- DNLI 2.1B
- IPO Year
- FFBC N/A
- DNLI 2017
- Fundamental
- Price
- FFBC $24.44
- DNLI $13.90
- Analyst Decision
- FFBC Hold
- DNLI Strong Buy
- Analyst Count
- FFBC 4
- DNLI 15
- Target Price
- FFBC $28.75
- DNLI $33.85
- AVG Volume (30 Days)
- FFBC 369.6K
- DNLI 1.7M
- Earning Date
- FFBC 07-24-2025
- DNLI 07-31-2025
- Dividend Yield
- FFBC 3.94%
- DNLI N/A
- EPS Growth
- FFBC N/A
- DNLI N/A
- EPS
- FFBC 2.41
- DNLI N/A
- Revenue
- FFBC $763,576,000.00
- DNLI N/A
- Revenue This Year
- FFBC $17.60
- DNLI N/A
- Revenue Next Year
- FFBC $4.79
- DNLI $335.74
- P/E Ratio
- FFBC $10.10
- DNLI N/A
- Revenue Growth
- FFBC N/A
- DNLI N/A
- 52 Week Low
- FFBC $21.10
- DNLI $10.57
- 52 Week High
- FFBC $31.18
- DNLI $33.33
- Technical
- Relative Strength Index (RSI)
- FFBC 58.31
- DNLI 51.89
- Support Level
- FFBC $22.98
- DNLI $13.41
- Resistance Level
- FFBC $24.47
- DNLI $14.79
- Average True Range (ATR)
- FFBC 0.57
- DNLI 0.61
- MACD
- FFBC 0.09
- DNLI 0.01
- Stochastic Oscillator
- FFBC 97.59
- DNLI 45.61
About FFBC First Financial Bancorp.
First Financial Bancorp is a mid-sized, regional bank holding company. It engages in the business of commercial banking and other banking and banking-related activities through its subsidiary. The range of banking services provided to individuals and businesses includes commercial lending, real estate lending and consumer financing. Real estate loans are loans secured by a mortgage lien on the real property of the borrower, which may either be residential property or commercial property. In addition, it offers deposit products that include interest-bearing and noninterest-bearing accounts, time deposits and cash management services for commercial customers. A full range of trust and wealth management services is also provided through First Financial's Wealth Management line of business.
About DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.